Edinburgh University has invested £1.2m in Nuclear Magnetic Resonance (NMR) and Mass Spectroscopy instrumentation to build on its position as a centre of excellence for molecular science.
The investment, funded by Core Capability EPSRC (Engineering and Physical Sciences Research Council) and the Edinburgh University, will support the installation of NMR and Mass Spectroscopy instrumentation, providing the chemical sciences industry with tools capable of handling an array of molecular constituents, across a broad spectrum of chemical and proteomic sampling.
Once installed, the instruments will offer greater efficiencies in terms of higher sensitivity, shorter measurement times, high throughput, better accuracy and superior characterisation.
Throughputs by Ingenza, a biocatalyst and bioprocess development company serving the pharmaceutical, food, fine chemical and biofuel industries, claims that the new NMR spectroscopy ‘provides an almost instantaneous turnover of samples which is a huge benefit to research efforts.’
Edinburgh Research and Innovation (ERI), the commercialisation arm of Edinburgh University, will look to develop commercial opportunities for the instrumentation.
NMR delivers structural determination and identification of a range of materials including small organic/inorganic molecules, steroids, antibiotics, carbohydrates, lipids, polypeptides, proteins, nucleic acids and complex mixtures.
Similarly, mass spectrometry is an analytical tool that can help answer a range of biological and chemical questions, such as the identification and characterisation of proteins, itself an area of interest to researchers involved in the discovery of new therapeutic targets and to the biopharmaceutical industry for the characterisation of new potential products.